Dexcom (Nasdaq:DXCM) announced that all people with type 1 and type 2 diabetes in Manitoba, Canada, meet eligibility criteria for its G6 CGM.
As of the company’s announcement, Manitoba is the only province in Canada that does not require an application for coverage preapproval. That means improved access for patients and a reduced workload for prescribers.
Expanded coverage establishes Manitoba as the leader in coverage for real-time continuous glucose monitoring (rtCGM) among Canadian provinces.
Get the full story at our sister site, Drug Delivery Business News.